Douglas B. Evans, MD discusses the multidisciplinary Pancreatic Cancer Program at the Medical College of Wisconsin with Parag Tolat, MD, Beth Erickson-Wittman, MD, Susan Tsai, MD, MHS and Paul Ritch, MD. Part Two addresses advances in chemotherapy for pancreatic cancer, how clinical trials drive advancements in the treatment of pancreatic cancer and the trials available through the Program, radiation therapy techniques, how indeterminate liver lesions are monitored throughout treatment, and the invaluable contributions of other Program members such as gastroenterologists, diabetes and nutrition counselors, advanced practice providers, and navigators who guide patients through their treatment journey.
![](https://i.ytimg.com/vi/HD6p882T0hI/maxresdefault.jpg)